ERBB2 and neoplasm: Third, decreased expression of individual tumor-intrinsic mesenchymal markers was confirmed in HER2 positive biopsies; mesenchymal markers such as CDH2, ZEB1, and SNAI1 showed higher expression in the HER2 negative cohort (p < 0.001; Fig. 2E).